STOCK TITAN

Vertex to Present at the J.P. Morgan Healthcare Conference on January 11

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vertex Pharmaceuticals (Nasdaq: VRTX) will present at the J.P. Morgan Healthcare Conference on January 11, 2021, at 9:10 a.m. ET. Interested parties can access the live audio through the company's website at www.vrtx.com. Vertex is a global biotech firm focused on creating medicines for serious diseases, particularly cystic fibrosis. The company has a robust pipeline in various conditions, including genetic and cell therapies for sickle cell disease, beta thalassemia, and more. Vertex is recognized for its workplace environment and commitment to innovation.

Positive
  • None.
Negative
  • None.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 9:10 a.m. ET (6:10 a.m. PT).

The audio portion of management’s remarks can be accessed live through Vertex’s website, www.vrtx.com, in the “Investors” section under the “News and Events” page. A replay of the conference webcast will be archived on the company’s website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create medicines for people with serious diseases. The company has multiple approved medicines that treat cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, Vertex has a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus.

Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 11 consecutive years on Science magazine's Top Employers list and a best place to work for LGBTQ equality by the Human Rights Campaign. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com

(VRTX-WEB)

FAQ

When is Vertex Pharmaceuticals presenting at the J.P. Morgan Healthcare Conference?

Vertex Pharmaceuticals will present on January 11, 2021, at 9:10 a.m. ET.

Where can I listen to Vertex Pharmaceuticals' presentation at the conference?

The audio of Vertex Pharmaceuticals' presentation can be accessed live at www.vrtx.com in the 'Investors' section.

What are Vertex Pharmaceuticals' main areas of focus?

Vertex Pharmaceuticals focuses on serious diseases, particularly cystic fibrosis, and has a pipeline in genetic and cell therapies.

What is Vertex Pharmaceuticals' stock symbol?

The stock symbol for Vertex Pharmaceuticals is VRTX.

What recognition has Vertex Pharmaceuticals received for its workplace?

Vertex Pharmaceuticals has been recognized as one of the industry's top places to work for 11 consecutive years.

Vertex Pharmaceuticals Inc

NASDAQ:VRTX

VRTX Rankings

VRTX Latest News

VRTX Stock Data

118.29B
257.53M
0.09%
95.96%
1.66%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BOSTON